Features Screener Stocks Charts
Sign In Sign Up

Divis Laboratories Ltd. Income Statement

NSE:DIVISLAB | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year DIVISLAB income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 81.84B 97.12B
Cost of Revenue -31.29B -37.25B
Gross Profit 50.55B 59.87B
Sales, General & Admin -25.11B -26.67B
Operating Income 21.66B 29.18B
Profit Before Tax 21.63B 29.16B
Net Income 16.00B 21.91B
Diluted Shares 265.47M 265.48M
Diluted EPS 60.27 82.53

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025